ITN's mission is to advance the clinical application of immune tolerance therapies and biomarker development by performing high quality clinical trials of emerging therapeutics integrated with mechanism-based research with a focus on allergy & asthma, organ transplantation, and autoimmune disease including Type 1 diabetes.